DaVita Inc. (NYSE:DVA) Shares Sold by Victory Capital Management Inc.

Victory Capital Management Inc. lessened its stake in shares of DaVita Inc. (NYSE:DVA) by 10.6% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 90,356 shares of the company’s stock after selling 10,768 shares during the period. Victory Capital Management Inc. owned 0.10% of DaVita worth $12,521,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Blue Trust Inc. raised its stake in DaVita by 58.6% during the second quarter. Blue Trust Inc. now owns 211 shares of the company’s stock worth $29,000 after purchasing an additional 78 shares during the period. Newbridge Financial Services Group Inc. purchased a new stake in shares of DaVita during the 4th quarter valued at approximately $30,000. Principal Securities Inc. acquired a new position in DaVita in the fourth quarter valued at approximately $37,000. Family Firm Inc. purchased a new position in DaVita in the second quarter worth approximately $43,000. Finally, Versant Capital Management Inc raised its position in DaVita by 90.6% in the second quarter. Versant Capital Management Inc now owns 326 shares of the company’s stock valued at $45,000 after purchasing an additional 155 shares during the period. Institutional investors and hedge funds own 90.12% of the company’s stock.

Insider Activity

In other DaVita news, CEO Javier Rodriguez sold 32,176 shares of the stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $155.93, for a total value of $5,017,203.68. Following the sale, the chief executive officer now directly owns 905,659 shares of the company’s stock, valued at approximately $141,219,407.87. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. In related news, CFO Joel Ackerman sold 64,029 shares of the business’s stock in a transaction that occurred on Tuesday, August 27th. The stock was sold at an average price of $155.06, for a total transaction of $9,928,336.74. Following the completion of the sale, the chief financial officer now owns 111,481 shares in the company, valued at $17,286,243.86. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Javier Rodriguez sold 32,176 shares of the stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $155.93, for a total transaction of $5,017,203.68. Following the completion of the transaction, the chief executive officer now owns 905,659 shares in the company, valued at $141,219,407.87. The disclosure for this sale can be found here. In the last quarter, insiders sold 113,601 shares of company stock worth $17,525,449. 2.00% of the stock is currently owned by company insiders.

DaVita Price Performance

DaVita stock opened at $163.56 on Friday. The company has a quick ratio of 1.12, a current ratio of 1.16 and a debt-to-equity ratio of 9.94. DaVita Inc. has a 52-week low of $71.51 and a 52-week high of $163.59. The firm has a market cap of $13.72 billion, a PE ratio of 18.59, a price-to-earnings-growth ratio of 0.90 and a beta of 0.87. The company’s 50 day moving average is $145.17 and its two-hundred day moving average is $139.91.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $2.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.47 by $0.12. DaVita had a return on equity of 77.00% and a net margin of 6.86%. The business had revenue of $3.19 billion for the quarter, compared to analysts’ expectations of $3.15 billion. During the same period last year, the firm earned $2.08 earnings per share. The company’s revenue for the quarter was up 6.2% compared to the same quarter last year. On average, research analysts expect that DaVita Inc. will post 9.99 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on DVA shares. UBS Group raised their price objective on DaVita from $169.00 to $175.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. Truist Financial boosted their price target on shares of DaVita from $150.00 to $165.00 and gave the company a “hold” rating in a research note on Tuesday, August 20th. StockNews.com cut shares of DaVita from a “strong-buy” rating to a “buy” rating in a research report on Saturday, June 8th. Bank of America boosted their target price on DaVita from $139.00 to $145.00 and gave the company an “underperform” rating in a research report on Wednesday, August 7th. Finally, TD Cowen raised their price target on DaVita from $139.00 to $150.00 and gave the stock a “hold” rating in a research report on Wednesday, July 24th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, DaVita presently has an average rating of “Hold” and a consensus target price of $157.00.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.